Table 1.
AMA (n=26) | Non-AMA (n=20) | Treatment Complete (n=83) | P Value | |
---|---|---|---|---|
Female | 3 (12)a,b | 0 (0)b | 22 (27)a | .01 |
Race/ethnicity | .22 | |||
White non-Hispanic | 12 (46) | 12 (60) | 27 (33) | |
Hispanic | 10 (39) | 6 (30) | 41 (49) | |
Black non-Hispanic | 4 (15) | 2 (10) | 15 (18) | |
Age, y | 41 ± 12 | 43 ± 8 | 45 ± 10 | .15 |
Drug of choice | ||||
Cocaine | 7 (27)a | 8 (40)a,b | 45 (54)b | .04 |
Heroin | 9 (35) | 3 (15) | 26 (31) | .29 |
Methamphetamines | 14 (54) | 10 (50) | 41 (49) | .46 |
Phencyclidine | 2 (8) | 1 (5) | 1 (1) | .22 |
Prescription drugs | 1 (4) | 2 (10) | 1 (1) | .12 |
Discharge diagnosis | ||||
Endocarditis | 7 (27) | 1 (5) | 8 (10) | .05 |
Bacteremia | 6 (23) | 6 (30) | 31 (37) | .38 |
Bone and joint | 13 (50) | 10 (50) | 35 (42) | .69 |
Skin and soft tissue | 0 (0) | 0 (0) | 4 (5) | .32 |
Diabetic foot infection | 5 (19) | 4 (20) | 14 (17) | .93 |
Pulmonary | 0 (0) | 2 (10) | 5 (6) | .31 |
GI/GU | 0 (0) | 0 (0) | 2 (2) | .57 |
CNS/ENT | 0 (0) | 2 (10) | 4 (5) | .28 |
Antibiotic at discharge | ||||
Cephalosporin | 16 (62) | 8 (40) | 48 (58) | .29 |
Vancomycin | 0 (0) | 10 (50) | 23 (28) | .16 |
Carbapenem | 0 (0) | 1 (5) | 7 (8) | .29 |
Penicillin | 2 (8) | 4 (20) | 12 (15) | .48 |
Daptomycin | 0 (0) | 0 (0) | 1 (1) | .76 |
Duration of planned antibiotic treatment, d | 31 (22–34) | 32 (18–35) | 28 (15–33) | .36 |
Duration of actual antibiotic treatment, d | 3 (2–11) | 21 (9–31) | 28 (20–35) | <.01 |
Table 1 demonstrates demographic and clinical variables including drug of choice, final diagnosis, and details regarding antibiotic treatment and duration among people who use drugs discharged to short-term nursing facilities for extended courses of intravenous antibiotics (n=129). Data are presented as No. (%), median (IQR), or mean ± SD.
Abbreviations: AMA, against medical advice; CNS/ENT, Central Nervous System/Ear Nose and Throat; GI/GU, Gastroenterology/Genitourinary; IQR, interquartile range.